{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:55:18Z","timestamp":1777996518483,"version":"3.51.4"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,25]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Coronavirus disease 2019 (COVID-19) has spread rapidly worldwide, leading to a pandemic. In China, Xiyanping injection (XYP) has been recommended as a drug for COVID-19 treatment in the Guideline on Diagnosis and Treatment of COVID-19 by the National Health Commission of the People Republic of China and National Administration of Traditional Chinese Medicine (Trial eighth Edition). However, the relevant mechanisms at the molecular-level need to be further elucidated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In this study, XYP related active ingredients, potential targets and COVID-19 related genes were searched in public databases. Protein-protein interaction network and module analyzes were used to screen for key targets. gene ontology and Kyoto encyclopedia of genes and genomes were performed to investigate the potentially relevant signaling pathways. Molecular docking was performed using Autodock Tools and Vina. For the validation of potential mechanism, PolyI:C was used to induce human lung epithelial cells for an inflammation model. Subsequently, CCK-8 assays, enzyme-linked immunosorbent assay, reverse transcription quantitative polymerase chain reaction and western blot were employed to determine the effect of XYP on the expression of key genes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Seven effective active ingredients in XYP were searched for 123 targets in the relevant databases. Furthermore, 6446 COVID-19 disease targets were identified. Sodium 9-dehydro-17-hydro-andrographolide-19-yl sulfate was identified as the vital active compounds, and IL-6, TNF, IL-1\u03b2, CXCL8, STAT3, MAPK1, MAPK14, and MAPK8 were considered as the key targets. In addition, molecular docking revealed that the active compound and the targets showed good binding affinities. The enrichment analysis predicted that the XYP could regulate the IL-17, Toll-like receptor, PI3K-Akt and JAK-STAT signaling pathways. Consistently, further in vitro experiments demonstrated that XYP could slow down the cytokine storm in the lung tissue of COVID-19 patients by down-regulating IL-6, TNF-\u03b1, IL-1\u03b2, CXCL8, and p-STAT3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Through effective network pharmacology analysis and molecular docking, this study suggests that XYP contains many effective compounds that may target COVID-19 related signaling pathways. Moreover, the in vitro experiment confirmed that XYP could inhibit the cytokine storm by regulating genes or proteins related to immune and inflammatory responses.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000034866","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T22:01:12Z","timestamp":1693432872000},"page":"e34866","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Integrated network pharmacology analysis and in vitro validation revealed the underlying mechanism of Xiyanping injection in treating coronavirus disease 2019"],"prefix":"10.1097","volume":"102","author":[{"given":"Jialin","family":"Li","sequence":"first","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China"},{"name":"College of Pharmacy, Harbin Medical University-Daqing, Daqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyu","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhishan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony","family":"Stalin","sequence":"additional","affiliation":[{"name":"Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanqin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinkui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiarui","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1749-8546-8-2","article-title":"Changes in the contents of four active diterpenoids at different growth stages in Andrographis paniculata (Burm. f.) Nees (Chuanxinlian).","volume":"8","author":"Pholphana","year":"2013","journal-title":"Chin Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"274905","DOI":"10.1155\/2014\/274905","article-title":"Andrographis paniculata (Burm. f.) Wall. ex Nees: a review of ethnobotany, phytochemistry, and pharmacology.","volume":"2014","author":"Hossain","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.phytochem.2004.05.008","article-title":"Flavonoids and andrographolides from Andrographis paniculata.","volume":"65","author":"Koteswara Rao","year":"2004","journal-title":"Phytochem"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.2174\/0929867327666200810135604","article-title":"Current trends on repurposing and pharmacological enhancement of andrographolide.","volume":"28","author":"Ren","year":"2021","journal-title":"Curr Med Chem"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.4103\/0973-1296.182194","article-title":"In vitro metabolism of sodium 9-dehydro-17-hydro-andrographolide-19-yl Sulfate in Rat Liver S9 by liquid chromatography-mass spectrometry method.","volume":"12","author":"Zheng","year":"2016","journal-title":"Pharmacogn Mag"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/jphp.13028","article-title":"Crystal structure and anti-inflammatory and anaphylactic effects of andrographlide sulphonate E in Xiyanping, a traditional Chinese medicine injection.","volume":"71","author":"Yang","year":"2019","journal-title":"J Pharm Pharmacol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1093\/cid\/ciaa631","article-title":"Chronological changes of viral shedding in adult inpatients with COVID-19 in Wuhan, China.","volume":"71","author":"Huang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19.","volume":"383","author":"Boulware","year":"2020","journal-title":"N Engl J Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19.","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cid\/ciaa272","article-title":"Clinical features of 69 cases with Coronavirus disease 2019 in Wuhan, China.","volume":"71","author":"Wang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3389\/fphar.2020.01066","article-title":"Chinese patent medicines in the treatment of Coronavirus disease 2019 (COVID-19) in China.","volume":"11","author":"Zhuang","year":"2020","journal-title":"Front Pharmacol"},{"key":"R12-20250504","first-page":"206","article-title":"Traditional Chinese medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP).","volume":"18","author":"Du","year":"2020","journal-title":"Chin J Nat Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"112842","DOI":"10.1016\/j.jep.2020.112842","article-title":"Network pharmacology and metabolomics study on the intervention of traditional Chinese medicine Huanglian Decoction in rats with type 2 diabetes mellitus.","volume":"258","author":"Pan","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"R14-20250504","first-page":"941","article-title":"Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019.","volume":"18","author":"Xing","year":"2020","journal-title":"Chin J Nat Med"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"153336","DOI":"10.1016\/j.phymed.2020.153336","article-title":"Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW.","volume":"79","author":"Zheng","year":"2020","journal-title":"Phytomedicine"},{"key":"R16-20250504","first-page":"881","article-title":"Recent advances of traditional Chinese medicine on the prevention and treatment of COVID-19.","volume":"18","author":"Dai","year":"2020","journal-title":"Chin J Nat Med"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/10286020.2013.803473","article-title":"Potential anti-angiogenic sulfates of andrographolide.","volume":"15","author":"Xiao","year":"2013","journal-title":"J Asian Nat Prod Res"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/bmc.2866","article-title":"Simultaneous determination of 9-dehydro-17- hydro-andrographolide and sodium 9-dehydro-17-hydro-andrographo-lide-19- yl sulfate in rat plasma by UHPLC-ESI-MS\/MS after administration of Xiyanping injection: application to a pharmacokinetic study.","volume":"27","author":"Chong","year":"2013","journal-title":"Biomed Chromatogr"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1758-2946-3-32","article-title":"PubChem3D: a new resource for scientists.","volume":"3","author":"Bolton","year":"2011","journal-title":"J Cheminform"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1021\/ci049794h","article-title":"Personal experience with four kinds of chemical structure drawing software: review on ChemDraw, ChemWindow, ISIS\/Draw, and ChemSketch.","volume":"44","author":"Li","year":"2004","journal-title":"J Chem Inf Comput Sci"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"W32","DOI":"10.1093\/nar\/gku293","article-title":"SwissTargetPrediction: a web server for target prediction of bioactive small molecules.","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"bax028","DOI":"10.1093\/database\/bax028","article-title":"GeneHancer: genome-wide integration of enhancers and target genes in GeneCards.","volume":"2017","author":"Fishilevich","year":"2017","journal-title":"Database (Oxford)"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"D793","DOI":"10.1093\/nar\/gkn665","article-title":"McKusick\u2019s online mendelian inheritance in man (OMIM).","volume":"37","author":"Amberger","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"D1398","DOI":"10.1093\/nar\/gkab953","article-title":"Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents.","volume":"50","author":"Zhou","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/35075138","article-title":"Lethality and centrality in protein networks.","volume":"411","author":"Jeong","year":"2001","journal-title":"Nature"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.socnet.2004.11.009","article-title":"A measure of betweenness centrality based on random walks.","volume":"27","author":"Newman","year":"2005","journal-title":"Soc Networks"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"858633","DOI":"10.3389\/fcell.2022.858633","article-title":"Identification of potential biomarkers and small molecule drugs for cutaneous melanoma using integrated bioinformatic analysis.","volume":"10","author":"Liu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.12659\/MSM.912450","article-title":"Identification of RNA expression profiles in thyroid cancer to construct a competing endogenous RNA (ceRNA) network of mRNAs, long noncoding RNAs (lncRNAs), and microRNAs (miRNAs).","volume":"25","author":"Xu","year":"2019","journal-title":"Med Sci Monit"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/jpm12030478","article-title":"Sensory ion channel candidates inform on the clinical course of pancreatic cancer and present potential targets for repurposing of FDA-approved agents.","volume":"12","author":"Shi","year":"2022","journal-title":"J Pers Med"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1631\/jzus.B1900071","article-title":"Catalpol ameliorates LPS-induced endometritis by inhibiting inflammation and TLR4\/NF-\u03baB signaling.","volume":"20","author":"Zhang","year":"2019","journal-title":"J Zhejiang Univ Sci B"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12974-020-1731-x","article-title":"Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2\/MyD88\/NF-\u03baB signaling pathway in spinal microglia.","volume":"17","author":"Yang","year":"2020","journal-title":"J Neuroinflammation"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"5818107","DOI":"10.1155\/2020\/5818107","article-title":"Network pharmacology integrated molecular docking reveals the mechanism of anisodamine hydrobromide injection against novel coronavirus pneumonia.","volume":"2020","author":"Su","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"104939","DOI":"10.1016\/j.phrs.2020.104939","article-title":"Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19).","volume":"158","author":"Huang","year":"2020","journal-title":"Pharmacol Res"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jmv.25783","article-title":"Clinical features and treatment of COVID-19 patients in northeast Chongqing.","volume":"92","author":"Wan","year":"2020","journal-title":"J Med Virol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1002\/ptr.7141","article-title":"Efficacy and safety of Xiyanping injection in the treatment of COVID-19: a multicenter, prospective, open-label and randomized controlled trial.","volume":"35","author":"Zhang","year":"2021","journal-title":"Phytother Res"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jphs.2020.08.005","article-title":"Andrographolide sulfate inhibited NF-\u03baB activation and alleviated pneumonia induced by poly I:C in mice.","volume":"144","author":"Cui","year":"2020","journal-title":"J Pharmacol Sci"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"972067","DOI":"10.1155\/2015\/972067","article-title":"Evaluating Andrographolide as a Potent Inhibitor of NS3-4A protease and its drug-resistant mutants using in silico approaches.","volume":"2015","author":"Chandramohan","year":"2015","journal-title":"Adv Virol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"8248142","DOI":"10.1155\/2017\/8248142","article-title":"Andrographolide inhibits inflammatory cytokines secretion in LPS-stimulated RAW264.7 cells through suppression of NF-\u03baB\/MAPK signaling pathway.","volume":"2017","author":"Li","year":"2017","journal-title":"Evid Based Complement Alternat Med"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the `Cytokine Storm\u2019 in COVID-19.","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"e12989","DOI":"10.1111\/sji.12989","article-title":"T cell immunobiology and cytokine storm of COVID-19.","volume":"93","author":"Luo","year":"2021","journal-title":"Scand J Immunol"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19.","volume":"93","author":"Hu","year":"2021","journal-title":"J Med Virol"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/JLB.3COVR0520-272R","article-title":"Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.","volume":"108","author":"Wang","year":"2020","journal-title":"J Leukoc Biol"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2017.83","article-title":"The role of IL-6 in host defence against infections: immunobiology and clinical implications.","volume":"13","author":"Rose-John","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"e20200678","DOI":"10.1084\/jem.20200678","article-title":"The many faces of the anti-COVID immune response.","volume":"217","author":"Vardhana","year":"2020","journal-title":"J Exp Med"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression.","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","article-title":"Detectable serum severe acute respiratory syndrome Coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with Coronavirus disease 2019.","volume":"71","author":"Chen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"104673","DOI":"10.1016\/j.micpath.2020.104673","article-title":"The interplay between inflammatory pathways and COVID-19: a critical review on pathogenesis and therapeutic options.","volume":"150","author":"Choudhary","year":"2021","journal-title":"Microb Pathog"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19).","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov Ther"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"283","DOI":"10.21037\/atm.2017.06.49","article-title":"Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise.","volume":"5","author":"Garc\u00eda-Laorden","year":"2017","journal-title":"Ann Transl Med"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"e92355","DOI":"10.1371\/journal.pone.0092355","article-title":"The pneumococcal polysaccharide capsule and pneumolysin differentially affect CXCL8 and IL-6 release from cells of the upper and lower respiratory tract.","volume":"9","author":"K\u00fcng","year":"2014","journal-title":"PLoS One"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"626235","DOI":"10.3389\/fimmu.2021.626235","article-title":"High levels of circulating IL-8 and Soluble IL-2R are associated with prolonged illness in patients with severe COVID-19.","volume":"12","author":"Ma","year":"2021","journal-title":"Front Immunol"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"e23656","DOI":"10.1097\/MD.0000000000023656","article-title":"The prognostic value of IL-8 for the death of severe or critical patients with COVID-19.","volume":"100","author":"Li","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.3390\/microorganisms9112259","article-title":"Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1\u03b2, Early Predictors of Severe COVID-19.","volume":"9","author":"Codina","year":"2021","journal-title":"Microorganisms"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system.","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"e12998","DOI":"10.1111\/sji.12998","article-title":"Coronavirus disease 2019 (COVID-19): an overview of the immunopathology, serological diagnosis and management.","volume":"93","author":"Anka","year":"2021","journal-title":"Scand J Immunol"},{"key":"R59-20250504","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome.","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"R60-20250504","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12964-018-0268-4","article-title":"Activation of the JAK\/STAT3 and PI3K\/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells.","volume":"16","author":"Zegeye","year":"2018","journal-title":"Cell Commun Signal"},{"key":"R61-20250504","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis.","volume":"19","author":"Guo","year":"2020","journal-title":"Exp Ther Med"},{"key":"R62-20250504","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1016\/j.csbj.2020.11.010","article-title":"Chinese herbal compounds against SARS-CoV-2: puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor.","volume":"18","author":"Pan","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"key":"R63-20250504","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11655-020-3476-x","article-title":"In Silico screening of potential Chinese herbal medicine against COVID-19 by targeting SARS-CoV-2 3CLpro and angiotensin converting enzyme II using molecular docking.","volume":"26","author":"Gao","year":"2020","journal-title":"Chin J Integr Med"},{"key":"R64-20250504","doi-asserted-by":"crossref","first-page":"bbab199","DOI":"10.1093\/bib\/bbab199","article-title":"Quercetin for COVID-19 and DENGUE co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and DENV.","volume":"22","author":"Zheng","year":"2021","journal-title":"Brief Bioinform"},{"key":"R65-20250504","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1002\/jmv.26826","article-title":"Role of Toll-like receptors in the pathogenesis of COVID-19.","volume":"93","author":"Khanmohammadi","year":"2021","journal-title":"J Med Virol"},{"key":"R66-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2021.09.005","article-title":"Targeting the PI3K\/Akt\/mTOR pathway: a therapeutic strategy in COVID-19 patients.","volume":"240","author":"Abu-Eid","year":"2021","journal-title":"Immunol Lett"},{"key":"R67-20250504","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/00325481.2020.1855921","article-title":"JAK-STAT pathway inhibition and their implications in COVID-19 therapy.","volume":"133","author":"Satarker","year":"2021","journal-title":"Postgrad Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:02:48Z","timestamp":1746327768000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":67,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034866","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]}}}